| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How to Create a Newsletter that Works - Part 2 |
|
Just Other Articles - How to Create a Newsletter that Works - Part 2
When trying to decide whether a newsletter is the way to go there are four elements you must consider that a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product re critical to its success; they are commitment, cost, frequency and size. Commitment The first thing ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in to consider when starting a newsletter is whether you and your staff can commit to this initiative over the lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ong run, which also includes supporting it financially. Make certain that everybody involved is on board fro here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe m the beginning and that once started you continue to publish it for a minimum period of time. You want peo d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ple to become familiar with your newsletter and turn into loyal readers. This takes time and consistency. St ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc rting one and then deciding to stop after a few issues may suggest to your readers a lack of commitment in o easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ther areas of your business. Frequency and Size What is the best frequency for sending newsletters? I nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically f you send something too often or make it too large, you may be hard pressed to find enough relevant content and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ for each issue. It is better to produce a smaller newsletter (two to four pages) more frequently than a lar ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ger publication at further intervals. Publish the newsletter frequently enough without overdoing it. Many ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a newsletters are published with too much time elapsing between issues giving customers more of an opportunity dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod to forget about your firm when they are looking for your type of service or product. Cost The cost of cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin producing a newsletter varies greatly and depends on a number of factors. Online and emailed versions cost tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen a lot less because there are no printing fees, but if you don’t have an in house communication department yo t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel will still have the costs related to hiring a writer and/or designer. If producing a print version, factor ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust s such as: paper stock, artwork, photographs, and colour versus black and white, should be considered; as we y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ll as quantity of distribution. You can circumvent the cost of publishing the newsletter by either printing . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de articles from outside sources (with written consent) or by soliciting other companies to advertise in it. Th elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e internet also has a myriad of e-zines that supply free or nominally feed content in a vast array of topics tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Work From Home As An E-Mail Customer Service Agent Part-Time/In-Home Business - Low Expense and Low Risk
|